In response to our clients’ growing interest in the development of therapies and other FDA-regulated consumer products derived from cannabis and its components, including cannabidiol (CBD), Alston & Bird has gathered experienced attorneys from across our firm to form a team that serves the needs of this developing area. Our team includes attorneys from coast to coast in our Washington, D.C., Atlanta, Los Angeles, New York, and Dallas offices. Join us for a complimentary three-part webinar series.
Part Two: Financing and Banking in the Cannabis Industry
Our panelists will address the banking and financial and private credit roadblocks the cannabis industry faces in the current regulatory landscape. Our team will discuss:
- The regulatory background on CBD and cannabis
- The current state of play
- Legislative updates on finance and banking services
- Opportunities and pitfalls for nonbank lenders to the cannabis industry
- Creative and alternative solutions the cannabis industry has adopted
Questions? Contact Abby Forness at email@example.com or 404.881.7824.